BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 20708006)

  • 21. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis E virus and the kidney in solid-organ transplant patients.
    Kamar N; Weclawiak H; Guilbeau-Frugier C; Legrand-Abravanel F; Cointault O; Ribes D; Esposito L; Cardeau-Desangles I; Guitard J; Sallusto F; Muscari F; Peron JM; Alric L; Izopet J; Rostaing L
    Transplantation; 2012 Mar; 93(6):617-23. PubMed ID: 22298032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
    Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
    Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief communication: case reports of ribavirin treatment for chronic hepatitis E.
    Mallet V; Nicand E; Sultanik P; Chakvetadze C; Tessé S; Thervet E; Mouthon L; Sogni P; Pol S
    Ann Intern Med; 2010 Jul; 153(2):85-9. PubMed ID: 20547886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience.
    Pischke S; Hardtke S; Bode U; Birkner S; Chatzikyrkou C; Kauffmann W; Bara CL; Gottlieb J; Wenzel J; Manns MP; Wedemeyer H
    Liver Int; 2013 May; 33(5):722-6. PubMed ID: 23489973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
    Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
    Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.
    Abravanel F; Lhomme S; Rostaing L; Kamar N; Izopet J
    Clin Infect Dis; 2015 Jan; 60(1):96-9. PubMed ID: 25249523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
    Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M
    J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.
    Wang Y; Chen G; Pan Q; Zhao J
    Gastroenterology; 2018 Mar; 154(4):1199-1201. PubMed ID: 29432746
    [No Abstract]   [Full Text] [Related]  

  • 31. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.
    Kamar N; Lhomme S; Abravanel F; Cointault O; Esposito L; Cardeau-Desangles I; Del Bello A; Dörr G; Lavayssière L; Nogier MB; Guitard J; Ribes D; Goin AL; Broué P; Metsu D; Sauné K; Rostaing L; Izopet J
    Transplantation; 2015 Oct; 99(10):2124-31. PubMed ID: 26214817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis E virus and chronic hepatitis in organ-transplant recipients.
    Kamar N; Selves J; Mansuy JM; Ouezzani L; Péron JM; Guitard J; Cointault O; Esposito L; Abravanel F; Danjoux M; Durand D; Vinel JP; Izopet J; Rostaing L
    N Engl J Med; 2008 Feb; 358(8):811-7. PubMed ID: 18287603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection with hepatitis E virus in kidney transplant recipients in southeastern France.
    Moal V; Legris T; Burtey S; Morange S; Purgus R; Dussol B; Garcia S; Motte A; Gérolami R; Berland Y; Colson P
    J Med Virol; 2013 Mar; 85(3):462-71. PubMed ID: 23239466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis E: when to treat and how to treat.
    Abbas Z; Afzal R
    Antivir Ther; 2014; 19(2):125-31. PubMed ID: 24192696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient.
    Kamar N; Abravanel F; Garrouste C; Cardeau-Desangles I; Mansuy JM; Weclawiak H; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2010 Aug; 25(8):2792-5. PubMed ID: 20494897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
    Giannini EG; Basso M; Savarino V; Picciotto A
    Aliment Pharmacol Ther; 2010 Feb; 31(4):502-8. PubMed ID: 19925499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
    Pischke S; Suneetha PV; Baechlein C; Barg-Hock H; Heim A; Kamar N; Schlue J; Strassburg CP; Lehner F; Raupach R; Bremer B; Magerstedt P; Cornberg M; Seehusen F; Baumgaertner W; Klempnauer J; Izopet J; Manns MP; Grummer B; Wedemeyer H
    Liver Transpl; 2010 Jan; 16(1):74-82. PubMed ID: 19866448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.